Summary
Latest filing:
John B. Bode is Director of ZEVRA THERAPEUTICS, INC. (ZVRA). 3 SEC Form 4 filings on record going back to 2025, most recently on 26 March 2026. Most recent open-market trade: bought $46K of ZVRA on 20 August 2025. Lifetime open-market purchases: $46K.
Recent Transactions
4Every recent SEC Form 4 transaction John B. Bode has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies John B. Bode files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Neil F. McFarlane - $1.19M of ZVRA open-market activity in the last 12 months
- Rahsaan Thompson - $969K of ZVRA open-market activity in the last 12 months
- Corey Michael Watton - $138K of ZVRA open-market activity in the last 12 months
- Brett Widney Hoge - $136K of NWTG open-market activity in the last 12 months
- Joshua Schafer - $126K of ZVRA open-market activity in the last 12 months
- Gregor Alasdair Campbell - $56K of NWTG open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is John B. Bode?
John B. Bode is a corporate insider, tracked as Director of ZEVRA THERAPEUTICS, INC. (ZVRA). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did John B. Bode last file a Form 4?
The most recent primary Form 4 on record is dated 26 March 2026, one of 3 filings going back to 2025.
Has John B. Bode been buying or selling stock?
Recorded transactions: 1 open-market purchase ($46K) and 0 open-market sales across all tracked filings.
Where can I see all of John B. Bode's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow John B. Bode and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
